» Authors » Julia Luthardt

Julia Luthardt

Explore the profile of Julia Luthardt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 616
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Ulke C, Rullmann M, Huang J, Luthardt J, Becker G, Patt M, et al.
Transl Psychiatry . 2019 Nov; 9(1):301. PMID: 31732713
The norepinephrine transporter (NET) has been suggested to play a critical role in attention-deficit/hyperactivity disorder (ADHD). In this prospective controlled study we tested the a-priori-hypothesis that central NET availability is...
12.
Tiepolt S, Luthardt J, Patt M, Hesse S, Hoffmann K, Weise D, et al.
J Alzheimers Dis . 2019 Jan; 68(1):65-76. PMID: 30636731
Background: Amyloid-β (Aβ) and [18F]FDG PET are established as amyloid pathology and neuronal injury biomarkers. Early after administration Aβ PET images have the potential to replace [18F]FDG PET images allowing...
13.
Florek L, Tiepolt S, Schroeter M, Berrouschot J, Saur D, Hesse S, et al.
J Alzheimers Dis . 2018 Nov; 66(3):1105-1116. PMID: 30400095
Background: Current research diagnostic criteria for Alzheimer's disease (AD) and mild cognitive impairment (MCI) due to AD include biomarkers to supplement clinical testing. Recently, we demonstrated that dual time-point [18F]FBB...
14.
Schinke C, Hesse S, Rullmann M, Becker G, Luthardt J, Zientek F, et al.
Stress . 2018 Oct; 22(1):93-102. PMID: 30369292
The central noradrenaline (NA) stress-response network co-mediates hypothalamic-pituitary-adrenal (HPA) axis activation and arginine-vasopressin (AVP) release. Dysregulation of these systems contributes to stress-related diseases such as human obesity, but their interrelation...
15.
Sabri O, Meyer P, Graf S, Hesse S, Wilke S, Becker G, et al.
Brain . 2018 Apr; 141(6):1840-1854. PMID: 29672680
In early Alzheimer's dementia, there is a need for PET biomarkers of disease progression with close associations to cognitive dysfunction that may aid to predict further cognitive decline and neurodegeneration....
16.
Vettermann F, Rullmann M, Becker G, Luthardt J, Zientek F, Patt M, et al.
Eur J Nucl Med Mol Imaging . 2018 Apr; 45(9):1618-1625. PMID: 29627935
Purpose: Although the mechanisms by which the central noradrenaline (NA) system influences appetite and controls energy balance are quite well understood, its relationship to changes in body weight remains largely...
17.
Hesse S, Muller U, Rullmann M, Luthardt J, Bresch A, Becker G, et al.
Psychiatry Res Neuroimaging . 2017 Jul; 267:9-14. PMID: 28675825
The brain noradrenaline (NA) system, particularly NA transporters (NAT), are thought to play an important role in modulating impulsive behavior. Impaired impulsivity is implicated in a variety of neuropsychiatric conditions;...
18.
Kaller S, Rullmann M, Patt M, Becker G, Luthardt J, Girbardt J, et al.
Eur J Nucl Med Mol Imaging . 2017 Feb; 44(6):1025-1032. PMID: 28197685
Purpose: The role of dopamine D-type receptor (DR)-expressing neurons in the regulation of motivated behavior and reward prediction has not yet been fully established. As a prerequisite for future research...
19.
Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, et al.
Psychoneuroendocrinology . 2017 Feb; 78:39-47. PMID: 28167369
Context: Increased activities of the arginine-vasopressin (AVP) system and the hypothalamic-pituitary-adrenal (HPA) axis were shown to be associated with human obesity, but relationships between these systems in obesity remain unclear....
20.
Hesse S, Becker G, Rullmann M, Bresch A, Luthardt J, Hankir M, et al.
Eur J Nucl Med Mol Imaging . 2017 Jan; 44(6):1056-1064. PMID: 28066877
Purpose: The brain noradrenaline (NA) system plays an important role in the central nervous control of energy balance and is thus implicated in the pathogenesis of obesity. The specific processes...